Anita Christina Chandrasekaran, MD
Rheumatology · Waterford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 11 years
- University of Connecticut School of Medicine, 2015
Offices
4 locations · Hartford Healthcare Medical Group Specialists PLLC · Telemedicine Group PC · Siskiyou Hospital Inc · St Peters Health
Hospitals listed: Lawrence & Memorial Hospital · Westerly Hospital · William W Backus Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chandrasekaran’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Lawrence & Memorial HospitalNew London, CTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Yale New Haven Health System, which runs 7 hospitals in 2 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.189, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.126, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.371, Oct 2024 – Sep 2025
- Westerly HospitalWesterly, RIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Yale New Haven Health System, which runs 7 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- William W Backus HospitalNorwich, CTAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Hartford Healthcare, which runs 10 hospitalsPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.041, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Lawrence & Memorial Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.189 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.126 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.371 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 865 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.69 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.99 (112.85 to 223.14) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 456 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 586 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.4 · 265 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,205 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,519 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.38 (0.18 to 0.57) · 5,615 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.7 (1.44 to 5.97) · 774 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.66 to 3.86) · 738 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.26 (1.91 to 18.61) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.07 (2.06 to 10.08) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.33) · 4,944 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 26 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.288 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 716 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 38.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 30.5 · 486 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.5 · 597 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (4.8 to 9.2) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 229 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.5 to 18.4) · 292 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.1) · 371 cases | No different | Jan 2024 – Dec 2024 |
What patients said (919 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Westerly Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 396 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.42 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 219 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17 · 267 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 50 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,332 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.42) · 1,957 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,008 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (1 to 5.89) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.82) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.84 (0 to 17.16) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.89 (0.69 to 9.08) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.34) · 1,735 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.143 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.7 · 317 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.8 · 236 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.4 · 275 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 454 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.4 to 7.6) · 141 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.4 to 15.8) · 141 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 134 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.9 to 18.5) · 978 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 283 cases | No different | Jan 2024 – Dec 2024 |
What patients said (689 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for William W Backus Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.041 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.21) · 907 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.43 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.13 (105.61 to 224.65) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 370 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 529 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 213 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 2,790 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,217 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 5,384 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.64 (0.5 to 4.78) · 872 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 344 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.93 (0.35 to 3.51) · 785 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.81 (0 to 12.1) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.94 (0.17 to 7.71) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 290 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.2) · 4,492 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 97 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.438 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.224 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 624 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.4 · 389 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.6 · 546 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 831 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.8 to 8.1) · 173 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.9 (6.6 to 12) · 173 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 307 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.1) · 539 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 505 cases | No different | Jan 2024 – Dec 2024 |
What patients said (955 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$33,461
Medicare paid this office $33,461 for 165 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 143 | $25,834 | $103 |
| New patient visit (45+ min) | 19 | $2,560 | $135 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 120 | $2,163 | $14 |
| Long return visit (40+ min) | 14 | $1,813 | $129 |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from medium joint | – | 12 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
165 Original Medicare patients in 2024. Average age 73 · Women 73% · Also on Medicaid 16% · Health risk score 1.51. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 28% · Depression 28% · Chronic kidney disease 26% · Coronary heart disease 20% · COPD 17% · Heart failure 16% · Atrial fibrillation 16% · Cancer 15% · Stroke 7%.
The office billed $102,315, Medicare allowed $44,736 and paid $33,461; for 649 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 165 | 649 | 73 | 1.51 | $102,315 | $33,461 |
| 2023 | 177 | 318 | 73 | 1.49 | $95,978 | $28,650 |
| 2022 | 221 | 489 | 73 | 1.39 | $149,468 | $47,429 |
| 2021 | 196 | 387 | 73 | 1.21 | $126,937 | $39,484 |
| 2020 | 11 | 14 | 69 | 0.84 | $4,485 | $1,353 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 145 | $21,598 | $90 |
| New patient visit (45+ min) | 28 | $3,562 | $127 |
| Long return visit (40+ min) | 14 | $2,280 | $152 |
2022: 4 services
| Return visit (30+ min) | 135 | $25,792 | $106 |
| New patient visit (45+ min) | 68 | $8,172 | $120 |
| Short return visit (20+ min) | 79 | $6,686 | $68 |
| Long return visit (40+ min) | 18 | $2,986 | $142 |
2021: 6 services
| New patient visit (45+ min) | 126 | $16,981 | $135 |
| Return visit (30+ min) | 55 | $9,255 | $105 |
| Short return visit (20+ min) | 56 | $5,413 | $77 |
| New patient visit (30+ min) | 39 | $3,595 | $92 |
| New patient visit (60+ min) | 13 | $2,398 | $184 |
| Aspiration and/or injection of fluid from medium joint | 11 | $496 | $41 |
Medicaid work
$1,235 in 2024
Medicaid paid $1,235 for 41 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 41 | $1,235 |
| 2024 | 41 | 1 | 16 | $1,235 |
| 2023 | 151 | 1 | 28 | $4,531 |
| 2022 | 80 | 1 | 20 | $2,210 |
| 2021 | 31 | 2 | 15 | $2,067 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 151 | $4,531 |
2022
| Return visit (30+ min) | 80 | $2,210 |
2021
| OFF/OP CNSLTJ NEW/EST MOD 40 | 17 | $1,547 |
| Return visit (30+ min) | 14 | $520 |
Drugs they prescribed that Part D paid
$1,890,332
Pharmacies billed $1,890,332 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,732) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
1,374 generic and 345 brand-name prescriptions · $1,890,332 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 64 | $451,689 | $7,058 |
| Humira(Cf) | 44 | $393,586 | $8,945 |
| Orencia Clickject | 29 | $156,707 | $5,404 |
| Rasuvo | 45 | $32,020 | $712 |
| Actemra Actpen | 13 | $30,882 | $2,376 |
See all 25 drugs
| Enbrel Sureclick | 64 | $451,689 | $7,058 |
| Humira(Cf) | 44 | $393,586 | $8,945 |
| Orencia Clickject | 29 | $156,707 | $5,404 |
| Rasuvo | 45 | $32,020 | $712 |
| Actemra Actpen | 13 | $30,882 | $2,376 |
| Otrexup | 19 | $18,868 | $993 |
| Hydroxychloroquine Sulfate | 328 | $12,504 | $38 |
| Mycophenolate Mofetil | 36 | $6,785 | $188 |
| Methotrexate | 238 | $5,766 | $24 |
| Cevimeline | 14 | $3,008 | $215 |
| Leflunomide | 36 | $2,265 | $63 |
| Azathioprine | 13 | $1,925 | $148 |
| Prednisone | 251 | $1,669 | $7 |
| Duloxetine | 48 | $1,362 | $28 |
| Pregabalin | 16 | $1,059 | $66 |
| Colchicine | 14 | $838 | $60 |
| Allopurinol | 65 | $798 | $12 |
| Methotrexate | 38 | $767 | $20 |
| Famotidine | 37 | $633 | $17 |
| Folic Acid | 56 | $476 | $9 |
| Gabapentin | 41 | $346 | $8 |
| Alendronate | 40 | $207 | $5 |
| Insulin | 13 | $111 | $9 |
| Methylprednisolone | 12 | $107 | $9 |
| Cyclobenzaprine | 11 | $24 | $2 |
Year by year
| 2024 | 1,732 | 324 | 0% (0) | 20% | $1,890,332 |
| 2023 | 1,723 | 322 | 0% (0) | 16% | $1,596,937 |
| 2022 | 1,764 | 307 | None | 14% | $1,714,782 |
| 2021 | 962 | 259 | 0% (0) | None | $608,945 |
| 2020 | 178 | 54 | 0% (0) | 16% | $104,536 |
| 2019 | 303 | 62 | 0% (0) | 28% | $266,898 |
| 2018 | 145 | 52 | 0% (0) | 26% | $107,390 |
| 2017 | 67 | 23 | None | None | $3,354 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Enbrel Sureclick | 57 | $457,579 | $8,028 |
| Humira(Cf) | 27 | $213,855 | $7,921 |
| Humira | 16 | $121,258 | $7,579 |
| Cosentyx Sensoready (2 Pens) | 14 | $106,157 | $7,583 |
| Actemra Actpen | 12 | $63,209 | $5,267 |
| Hydroxychloroquine Sulfate | 404 | $32,900 | $81 |
| Rasuvo | 18 | $12,892 | $716 |
| Methotrexate | 276 | $11,382 | $41 |
| Mycophenolate Mofetil | 46 | $10,604 | $231 |
| Colchicine | 16 | $3,105 | $194 |
| Leflunomide | 26 | $2,974 | $114 |
| Prednisone | 211 | $2,752 | $13 |
| Duloxetine | 63 | $2,332 | $37 |
| Allopurinol | 94 | $2,021 | $22 |
| Pregabalin | 39 | $1,484 | $38 |
| Methotrexate | 34 | $502 | $15 |
| Alendronate | 29 | $410 | $14 |
| Famotidine | 31 | $393 | $13 |
| Gabapentin | 19 | $252 | $13 |
| Folic Acid | 50 | $244 | $5 |
| Triamcinolone Acetonide | 12 | $241 | $20 |
| Insulin | 12 | $216 | $18 |
| Sulfamethoxazole-Trimethoprim | 12 | $50 | $4 |
2022: 23 drugs
| Enbrel Sureclick | 48 | $384,226 | $8,005 |
| Humira(Cf) | 42 | $284,804 | $6,781 |
| Humira | 16 | $109,501 | $6,844 |
| Orencia Clickject | 14 | $81,018 | $5,787 |
| Olumiant | 15 | $53,505 | $3,567 |
| Hydroxychloroquine Sulfate | 357 | $39,287 | $110 |
| Mycophenolate Mofetil | 55 | $13,817 | $251 |
| Methotrexate | 248 | $13,230 | $53 |
| Prednisone | 297 | $5,484 | $18 |
| Colchicine | 21 | $4,747 | $226 |
| Duloxetine | 71 | $4,232 | $60 |
| Leflunomide | 32 | $3,818 | $119 |
| Allopurinol | 99 | $2,185 | $22 |
| Pregabalin | 30 | $1,845 | $61 |
| Methotrexate | 51 | $724 | $14 |
| Famotidine | 40 | $600 | $15 |
| Alendronate | 39 | $552 | $14 |
| Sulfasalazine | 11 | $486 | $44 |
| Gabapentin | 17 | $379 | $22 |
| Insulin | 12 | $303 | $25 |
| Folic Acid | 46 | $298 | $6 |
| Methylprednisolone | 14 | $286 | $20 |
| Meloxicam | 12 | $101 | $8 |
2021: 17 drugs
| Enbrel Sureclick | 17 | $146,266 | $8,604 |
| Hydroxychloroquine Sulfate | 155 | $18,287 | $118 |
| Methotrexate | 105 | $6,458 | $62 |
| Prednisone | 257 | $3,997 | $16 |
| Leflunomide | 21 | $3,821 | $182 |
| Mycophenolate Mofetil | 19 | $3,272 | $172 |
| Colchicine | 15 | $2,747 | $183 |
| Allopurinol | 43 | $959 | $22 |
| Duloxetine | 17 | $849 | $50 |
| Diclofenac | 34 | $771 | $23 |
| Famotidine | 37 | $658 | $18 |
| Sulfasalazine | 16 | $406 | $25 |
| Methotrexate | 27 | $295 | $11 |
| Alendronate | 14 | $275 | $20 |
| Gabapentin | 11 | $221 | $20 |
| Meloxicam | 19 | $134 | $7 |
| Folic Acid | 17 | $132 | $8 |
2020: 5 drugs
| Colcrys | 11 | $3,619 | $329 |
| Hydroxychloroquine Sulfate | 27 | $2,411 | $89 |
| Methotrexate | 25 | $1,251 | $50 |
| Prednisone | 47 | $717 | $15 |
| Famotidine | 12 | $260 | $22 |
2019: 5 drugs
| Hydroxychloroquine Sulfate | 40 | $4,599 | $115 |
| Methotrexate | 38 | $2,470 | $65 |
| Azathioprine | 16 | $1,287 | $80 |
| Prednisone | 67 | $806 | $12 |
| Sulfasalazine | 13 | $521 | $40 |
2018: 3 drugs
| Hydroxychloroquine Sulfate | 12 | $1,664 | $139 |
| Methotrexate | 12 | $712 | $59 |
| Prednisone | 25 | $265 | $11 |
Money from drug and device companies
$332 in 2025
| 2025 | 5 | 12 | None | $332 |
| 2024 | 4 | 7 | None | $144 |
| 2023 | 1 | 1 | None | $16 |
| 2021 | 2 | 2 | None | $26 |
| 2020 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Enbrel | $104 | 5 payments
|
| GlaxoSmithKline | Benlysta | $100 | 4 payments
|
| Janssen Biotech | Tremfya | $87 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $21 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $20 | 1 payment
|
See all 12 published payments
| GlaxoSmithKline | Meals · 2025-10-21 | Benlysta | $24 |
| GlaxoSmithKline | Meals · 2025-08-06 | Benlysta | $25 |
| GlaxoSmithKline | Meals · 2025-07-09 | Benlysta | $23 |
| Amgen | Meals · 2025-05-28 | Otezla | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-20 | Orencia | $21 |
| Amgen | Meals · 2025-05-01 | Uplizna | $26 |
| Janssen Biotech | Meals · 2025-04-30 | Tremfya | $87 |
| GlaxoSmithKline | Meals · 2025-04-17 | Benlysta | $28 |
| Amgen | Meals · 2025-04-02 | Enbrel | $22 |
| Actelion Pharmaceuticals US | Meals · 2025-03-27 | Uptravi | $20 |
| Amgen | Meals · 2025-02-19 | Enbrel | $23 |
| Amgen | Meals · 2025-01-09 | Enbrel | $19 |
See earlier years (2024, 2023, 2021, 2020)
2024: $144
| GlaxoSmithKline | Benlysta | $63 | 3 payments
|
| Abbvie | Rinvoq | $35 | 2 payments
|
| Amgen | Enbrel | $26 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $20 | 1 payment
|
2023: $16
| AstraZeneca Pharmaceuticals LP | Saphnelo | $16 | 1 payment
|
2021: $26
| GlaxoSmithKline | Benlysta | $14 | 1 payment
|
| Amgen | Enbrel | $11 | 1 payment
|
2020: $12
| GlaxoSmithKline | Benlysta | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861870651
- Licence
- CT 66609
- Trained
- University of Connecticut School of Medicine, 2015 · 11 years ago
- Group
- Hartford Healthcare Medical Group Specialists PLLC · Telemedicine Group PC · Siskiyou Hospital Inc · St Peters Health
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 196 Waterford Pkwy S Ste 201b, Waterford, CT, 06385
- NPI first listed
- 2015-05-12
- NPI last updated
- 2020-08-13
- NPI record certified
- 2020-08-13
This is when the NPI record was last certified, not a medical board exam.